FdaApplication
ANDA 203053
Identifiers
- fda_app_no: ANDA203053
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2022-01-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 600MG;200MG;300MG | TABLET;ORAL |
1 product